Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 91832-40-5 | Product Number: C3111
Cefdinir
×
![]()
×
Purity: >97.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 1G |
$105.00
|
1 | 1 | 21 |
|
| 5G |
$263.00
|
1 | Contact Us | 6 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
| Product Number | C3111 |
| Purity / Analysis Method | >97.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__4H__1__3N__5O__5S__2 = 395.41 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 91832-40-5 |
| Reaxys Registry Number | 6829362 |
| PubChem Substance ID | 253660757 |
| Merck Index (14) | 1920 |
| MDL Number | MFCD00865030 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Specific rotation [a]20/D | -58.0 to -66.0 deg(C=1,0.1mol/L buffer sol. pH7.0 Phosphate) |
Properties (reference)
| Melting Point | 190 °C(dec.) |
| Specific Rotation | -65° (C=1,0.1mol/L pH7.0 phoshate Buffer) |
| Maximum Absorption Wavelength | 295(DMSO) nm |
| Solubility in water | Insoluble |
| Solubility (insoluble in) | Ether, Ethanol |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P285 : In case of inadequate ventilation wear respiratory protection. P280 : Wear protective gloves. P272 : Contaminated work clothing must not be allowed out of the workplace. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P304 + P341 : IF INHALED: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P363 : Wash contaminated clothing before reuse. |
Related Laws:
| RTECS# | XI0367250 |
Transport Information:
| HS Number | 2941.90.5000 |
Application
Cefdinir: A Third-Generation Cephalosporin More Active Against Gram-Positive Organisms
Cefdinir (FK482) is an oral third-generation cephalosporin with vinyl group at the 3-potition and 2-aminothiazolylhydroxyimino group at the 7-potition of 7-ACA [A1266]. Cefdinir has a broad spectrum of activity against many Gram-negative and Gram-positive organisms, but does not have activity against Pseudomonas aeruginosa. Cefdinir is more active than other cephalosporins (e.g. cephalexin [C2248]) against Gram-positive organisms such as Staphylococcus aureus and strains of the Streptococcus group. Cefdinir is stable to hydrolysis by β-lactamases. (The product is for research purpose only.)
References
- In vitro antibacterial activity of FK482, a new orally active cephalosporin
- Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin (a review)
- Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections (a review)
- Method development for the determination of cefdinir and its related substances by high-performance liquid chromatography
- Polymorphisms and Patent, Market, and Legal Battles: Cefdinir Case Study
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.